A real-world effectiveness and safety of elbasvir/grazoprevir in Hepatitis C genotype 1 patients
Latest Information Update: 26 Aug 2021
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatic fibrosis; Hepatitis C; Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 26 Aug 2021 New trial record